Dear BearDownAZ

Your explanation answers many of the questions I had and helps me to understand how RVX-208 and ZEN-3694 interact with other therapies. I'm beginning to grasp the extremely complex and onerous task at hand and the difficulty of pioneering this novel treatment.

Thank you so much for taking the time and sharing your valuable knowledge and expertise.

Sarah's comments regarding the Zenith reorganization suggest that an announcement on the trial commencement is imminent and priorities are in order.

Chicagoest